AMPA-receptor-mediated excitatory synaptic transmission is enhanced by iron-induced α-synuclein oligomers

Journal of Neurochemistry

Volumn 117, Issue 5, 2011, Pages 868-878

  Hüls, Sandra ^a   Högen, Tobias ^a   Vassallo, Neville ^b   Danzer, Karin M ^c   Hengerer, Bastian ^d   Giese, Armin ^a   Herms, Jochen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MALTA   (Malta)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

AMPA receptor; oligomer; Parkinson's disease; synaptic transmission; synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMPA RECEPTOR; FERRIC ION; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OLIGOMER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; EXCITOTOXICITY; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NEWBORN; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN AGGREGATION; SYNAPTIC TRANSMISSION;

ALPHA-SYNUCLEIN; ANIMALS; ASTROCYTES; CELL DEATH; CELL SURVIVAL; CEREBRAL CORTEX; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPHYSIOLOGICAL PHENOMENA; EXCITATORY POSTSYNAPTIC POTENTIALS; FLUORESCENT DYES; HIPPOCAMPUS; HUMANS; IRON; MICE; MICROSCOPY, CONFOCAL; PATCH-CLAMP TECHNIQUES; RECEPTORS, AMPA; RECOMBINANT PROTEINS; SYNAPTIC TRANSMISSION; TETRAZOLIUM SALTS; THIAZOLES;

EID: 79955671013     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07254.x     Document Type: Article

References (53)

1. Abeliovich A., Schmitz Y., Fariñas I., et al. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252. (Pubitemid 30316525)
2. Beattie E. C., Carroll R. C., Yu X., Morishita W., Yasuda H., von Zastrow M., and, Malenka R. C., (2000) Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat. Neurosci. 3, 1291-1300.
3. Bekkers J. M., and, Stevens C. F., (1991) Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc. Natl Acad. Sci. USA 88, 7834-7838. (Pubitemid 21915249)
4. Bertsch U., Winklhofer K. F., Hirschberger T., Bieschke J., Weber P., Hartl F. U., Tavan P., Tatzelt J., Kretzschmar H. A., and, Giese A., (2005) Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets. J. Virol. 79, 7785-7791. (Pubitemid 40756812)
5. Bieschke J., Giese A., Schulz-Schaeffer W., Zerr I., Poser S., Eigen M., and, Kretzschmar H., (2000) Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc. Natl Acad. Sci. USA 97, 5468-5473. (Pubitemid 30313742)
6. Biou V., Bhattacharyya S., and, Malenka R. C., (2008) Endocytosis and recycling of AMPA receptors lacking GluR2/3. Proc. Natl Acad. Sci. USA 105, 1038-1043. (Pubitemid 351282077)
7. Chan C. S., Gertler T. S., and, Surmeier D. J., (2009) Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci. 32, 249-256.
8. Cheng F., Vivacqua G., and, Yu S., (2011) The role of alpha-synuclein in neurotransmission and synaptic plasticity. J. Chem. Neuroanat. (in press), doi: 10.1016/j.jchemneu.2010.12.001.
9. Conway K. A., Lee S. J., Rochet J. C., Ding T. T., Williamson R. E., and, Lansbury P. T. Jr., (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl Acad. Sci. USA 97, 571-576. (Pubitemid 30070350)
10. Danzer K. M., Haasen D., Karow A. R., Moussaud S., Habeck M., Giese A., Kretzschmar H., Hengerer B., and, Kostka M., (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 27, 9220-9232. (Pubitemid 47312071)
11. Danzer K. M., Ruf W. P., Putcha P., Joyner D., Hashimoto T., Glabe C., Hyman B. T., and, McLean P. J., (2011) Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 25, 326-336.
12. Desplats P., Lee H. J., Bae E. J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., and, Lee S. J., (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl Acad. Sci. USA 106, 13010-13015.
13. El-Agnaf O. M., Salem S. A., Paleologou K. E., Curran M. D., Gibson M. J., Court J. A., Schlossmacher M. G., and, Allsop D., (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J. 20, 419-425. (Pubitemid 44933318)
14. Forman M. S., Lee V. M., and, Trojanowski J. Q., (2005) Nosology of Parkinson's disease: looking for the way out of a quagmire. Neuron 47, 479-482. (Pubitemid 41139206)
15. Giese A., Levin J., Bertsch U., and, Kretzschmar H., (2004) Effect of metal ions on de novo aggregation of full-length prion protein. Biochem. Biophys. Res. Commun. 320, 1240-1246. (Pubitemid 38916677)
16. Götz M. E., Double K., Gerlach M., Youdim M. B., and, Riederer P., (2004) The relevance of iron in the pathogenesis of Parkinson's disease. Ann. N Y Acad. Sci. 1012, 193-208. (Pubitemid 38455479)
17. Gureviciene I., Gurevicius K., and, Tanila H., (2007) Role of alpha-synuclein in synaptic glutamate release. Neurobiol. Dis. 28, 83-89. (Pubitemid 47429976)
18. Gureviciene I., Gurevicius K., and, Tanila H., (2009) Aging and alpha-synuclein affect synaptic plasticity in the dentate gyrus. J. Neural Transm. 116, 13-22.
19. Hashimoto M., and, Masliah E., (1999) Alpha-synuclein in Lewy body disease and Alzheimer's disease. Brain Pathol. 9, 707-720. (Pubitemid 29470963)
20. Hashimoto M., Kawahara K., Bar-On P., Rockenstein E., Crews L., and, Masliah E., (2004) The role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease. J. Mol. Neurosci. 24, 343-352. (Pubitemid 41389374)
21. Hatano T., Kubo S., Sato S., and, Hattori N., (2009) Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. J. Neurochem. 111, 1075-1093.
22. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H. A., Kittel A., and, Saitoh T., (1995) The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467-475.
23. Iwatsubo T., Yamaguchi H., Fujimuro M., Yokosawa H., Ihara Y., Trojanowski J. Q., and, Lee V. M., (1996) Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am. J. Pathol. 148, 1517-1529. (Pubitemid 26135893)
24. Kask P., Palo K., Fay N., Brand L., Mets U., Ullmann D., Jungmann J., Pschorr J., and, Gall K., (2000) Two-dimensional fluorescence intensity distribution analysis: theory and applications. Biophys. J. 78, 1703-1713. (Pubitemid 30183569)
25. Kayed R., Head E., Thompson J. L., McIntire T. M., Milton S. C., Cotman C. W., and, Glabe C. G., (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. (Pubitemid 36444329)
26. Kayed R., Sokolov Y., Edmonds B., McIntire T. M., Milton S. C., Hall J. E., and, Glabe C. G., (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366. (Pubitemid 39518276)
27. Koo E. H., Lansbury P. T. Jr., and, Kelly J. W., (1999) Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl Acad. Sci. USA 96, 9989-9990. (Pubitemid 29422496)
28. Kostka M., Högen T., Danzer K. M., et al. (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J. Biol. Chem. 283, 10992-11003.
29. Kramer M. L., and, Schulz-Schaeffer W. J., (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 27, 1405-1410.
30. Lansbury P. T. Jr., (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl Acad. Sci. USA 96, 3342-3344.
31. Lee M. K., Stirling W., Xu Y., Xu X., Qui D., Mandir A. S., Dawson T. M., Copeland N. G., Jenkins N. A., and, Price D. L., (2002) Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 - > Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl Acad. Sci. USA 99, 8968-8973. (Pubitemid 34693667)
32. Lee S. J., Desplats P., Sigurdson C., Tsigelny I., and, Masliah E., (2010) Cell-to-cell transmission of non-prion protein aggregates. Nat. Rev. Neurol. 6, 702-706.
33. Levin J., Bertsch U., Kretzschmar H., and, Giese A., (2005) Single particle analysis of manganese-induced prion protein aggregates. Biochem. Biophys. Res. Commun. 329, 1200-1207. (Pubitemid 40568698)
34. Mollenhauer B., Cullen V., Kahn I., et al. (2008) Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp. Neurol. 213, 315-325.
35. Mosmann T., (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63. (Pubitemid 14203433)
36. Murphy D. D., Rueter S. M., Trojanowski J. Q., and, Lee V. M., (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 3214-3220. (Pubitemid 30263139)
37. Nuscher B., Kamp F., Mehnert T., Odoy S., Haass C., Kahle P. J., and, Beyer K., (2004) Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study. J. Biol. Chem. 279, 21966-21975. (Pubitemid 38679387)
38. Priller C., Bauer T., Mitteregger G., Krebs B., Kretzschmar H. A., and, Herms J., (2006) Synapse formation and function is modulated by the amyloid precursor protein. J. Neurosci. 26, 7212-7221.
39. Priller C., Mitteregger G., Paluch S., Vassallo N., Staufenbiel M., Kretzschmar H. A., Jucker M., and, Herms J., (2009) Excitatory synaptic transmission is depressed in cultured hippocampal neurons of APP/PS1 mice. Neurobiol. Aging 30, 1227-1237.
40. Rhodes S. L., and, Ritz B., (2008) Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol. Dis. 32, 183-195.
41. Rosenmund C., Clements J. D., and, Westbrook G. L., (1993) Nonuniform probability of glutamate release at a hippocampal synapse. Science 262, 754-757. (Pubitemid 23350697)
42. Rosenmund C., Feltz A., and, Westbrook G. L., (1995) Calcium-dependent inactivation of synaptic NMDA receptors in hippocampal neurons. J. Neurophysiol. 73, 427-430.
43. Schneggenburger R., Meyer A. C., and, Neher E., (1999) Released fraction and total size of a pool of immediately available transmitter quanta at a calyx synapse. Neuron 23, 399-409. (Pubitemid 29315733)
44. Scholz K. P., and, Byrne J. H., (1987) Long-term sensitization in Aplysia: biophysical correlates in tail sensory neurons. Science 235, 685-687. (Pubitemid 17011110)
45. Snyder A. M., and, Connor J. R., (2009) Iron, the substantia nigra and related neurological disorders. Biochim. Biophys. Acta 1790, 606-614.
46. Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M., and, Goedert M., (1998) Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469-6473. (Pubitemid 28249037)
47. Steidl J. V., Gomez-Isla T., Mariash A., Ashe K. H., and, Boland L. M., (2003) Altered short-term hippocampal synaptic plasticity in mutant alpha-synuclein transgenic mice. Neuroreport 14, 219-223. (Pubitemid 36308414)
48. Thayer S. A., Usachev Y. M., and, Pottorf W. J., (2002) Modulating Ca2+ clearance from neurons. Front. Biosci. 7, 1255-1279.
49. Trojanowski J. Q., Goedert M., Iwatsubo T., and, Lee V. M., (1998) Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differ. 5, 832-837. (Pubitemid 28484393)
50. Tsigelny I. F., Bar-On P., Sharikov Y., Crews L., Hashimoto M., Miller M. A., Keller S. H., Platoshyn O., Yuan J. X., and, Masliah E., (2007) Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein. FEBS J. 274, 1862-1877. (Pubitemid 46426920)
51. Watson J. B., Hatami A., David H., Masliah E., Roberts K., Evans C. E., and, Levine M. S., (2009) Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein. Neuroscience 159, 501-513.
52. Wright P. E., and, Dyson J. H., (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293, 321-331. (Pubitemid 29516173)
53. Zempel H., Thies E., Mandelkow E., and, Mandelkow E. M., (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 30, 11938-11950.